We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

102 hedge funds and large institutions have $1.19B invested in Harmony Biosciences in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 9

50% more capital invested

Capital invested by funds: $790M → $1.19B (+$396M)

21% more funds holding

Funds holding: 84 → 102 (+18)

5.06% more ownership

Funds ownership: 49.2% → 54.26% (+5.1%)

3% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 30

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
102
Holders Change
+18
Holders Change %
+21.43%
% of All Funds
1.79%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
27
Increased
31
Reduced
30
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$62.4M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$39.9M
3
Blackstone Inc
Blackstone Inc
New York
+$33.8M
4
VC
Vivo Capital
California
+$11.3M
5
BlackRock
BlackRock
New York
+$9.96M

Top Sellers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
-$44.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$26.2M
3
NP
Newlight Partners
New York
-$24.7M
4
VP
venBio Partners
California
-$14.2M
5
ACM
Aisling Capital Management
New York
-$8.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
MB
26
MPM BioImpact
Massachusetts
$5.81M +$4.88M +151,650 New
RHJA
27
Rice Hall James & Associates
California
$5.34M -$39.4K -1,224 -0.9%
BG
28
Bellevue Group
Switzerland
$4.96M +$4.16M +129,289 New
BBA
29
Baker Bros. Advisors
New York
$4.74M – – –
AR
30
Advisory Research
Illinois
$4.56M +$3.83M +119,050 New
Comerica Bank
31
Comerica Bank
Texas
$3.93M +$3.1M +96,340 New
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$3.92M +$3.29M +102,292 New
LP
33
LMR Partners
United Kingdom
$3.83M +$3.22M +100,000 New
Deutsche Bank
34
Deutsche Bank
Germany
$3.5M +$266K +8,255 +10%
ECM
35
ExodusPoint Capital Management
New York
$3.36M +$539K +16,732 +24%
CI
36
Cambiar Investors
Colorado
$3.15M -$704K -21,861 -21%
Wells Fargo
37
Wells Fargo
California
$3.15M +$2.33M +72,383 +742%
GTC
38
Ghost Tree Capital
New York
$2.88M -$1.61M -50,000 -40%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.63M +$754K +23,407 +52%
SEI Investments
40
SEI Investments
Pennsylvania
$2.44M +$2.05M +63,718 New
CIBC Private Wealth Group
41
CIBC Private Wealth Group
Georgia
$2.3M +$32.2K +1,000 +2%
CSS
42
Cubist Systematic Strategies
Connecticut
$2.09M +$1.13M +34,947 +178%
Goldman Sachs
43
Goldman Sachs
New York
$2.09M +$836K +25,955 +91%
JF
44
Jump Financial
Illinois
$2.09M +$804K +24,955 +85%
Millennium Management
45
Millennium Management
New York
$2.06M -$3.07M -95,261 -64%
Morgan Stanley
46
Morgan Stanley
New York
$1.71M -$2.71M -84,272 -65%
Citadel Advisors
47
Citadel Advisors
Florida
$1.57M -$120K -3,724 -8%
NHAS
48
Novo Holdings A/S
Denmark
$1.53M -$44.5M -1,382,953 -97%
Renaissance Technologies
49
Renaissance Technologies
New York
$1.51M +$889K +27,600 +234%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.44M – – –
1
2
3 4 5

HRMY Hedge Fund Activity: Q3 2021 in Review

102 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q3 2021, worth a combined $1.19B — up 50% from $790M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new HRMY positions and 9 closed out — a net gain of 18 holders — while 31 added to existing stakes and 30 trimmed.

The largest buyer was Vanguard Group, adding an estimated $62.4M. The largest seller was Novo Holdings A/S, cutting an estimated $44.5M.

  • 102 institutional investors held Harmony Biosciences (HRMY) as of Q3 2021, up from 84 in Q2 2021.
  • Funds reported $1.19B of Harmony Biosciences stock for Q3 2021, up 50% quarter-over-quarter.
  • 27 funds opened new Harmony Biosciences positions in Q3 2021 and 9 closed out, a net change of +18 holders.
  • The largest Harmony Biosciences buyer in Q3 2021 was Vanguard Group, an estimated $62.4M added.
  • The largest Harmony Biosciences seller in Q3 2021 was Novo Holdings A/S, an estimated $44.5M sold.

Based on aggregated 13F filings for Q3 2021.